• -
23 Results
DMS 110122
Looking Back at Our Impact in 2022
In 2022, the nation faced fundamental questions about how we govern our economy and society — particularly how we formulate public policy. Here, we share 10 highlights of our work that illustrate our impact from the previous year.
David M. Satterfield December 21, 2022
Drugs and a gun with money in a pile
What the New U.S.-Mexico Deal Means for Drug Policy
This October the U.S. and Mexico agreed on a new bilateral security program, but "unless the United States and Mexico pursue domestic structural reforms ... both nations risk backsliding to the failures of the drug wars," writes MGA student and Drug Policy guest contributor Sidney Phillips.
The Baker Institute December 16, 2021
Global market trends chart
SPACs and Select Tax Considerations
Special purpose acquisition companies (SPACs) have experienced a massive surge in popularity over the last year. How do SPACs work, and what are some of the tax implications that investors may overlook? Public finance fellow Joyce Beebe explains on the Baker Institute Blog: https://bit.ly/3t5eMH8
Joyce Beebe April 29, 2021
Marijuana bud next to a gavel
The Cannabis Law & Policy Committee
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
Lisa Pittman July 28, 2020
Marijuana bud next to a gavel
New Frontiers: Hemp Law & Litigation
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
Lisa Pittman February 1, 2020
Marijuana
New Laws in Texas for Hemp
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
Lisa Pittman, Thomas Pittman February 1, 2020